{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:34:06Z","timestamp":1790685246185,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.therap.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T21:37:00Z","timestamp":1656538620000},"page":"334-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hospitalisations apr\u00e8s consommation de substances psychoactives pendant la pand\u00e9mie de COVID-19"],"prefix":"10.1016","volume":"78","author":[{"given":"Claire","family":"Dumoulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanta","family":"Ramaroson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Letinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Miremont-Salam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Gilleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Perino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.06.003_bib0055","doi-asserted-by":"crossref","first-page":"e20955","DOI":"10.2196\/20955","article-title":"Excessive media consumption about COVID-19\u00a0is associated with increased state anxiety: outcomes of a large online survey in Russia","volume":"22","author":"Nekliudov","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.therap.2022.06.003_bib0060","unstructured":"Canadian Centre on Substance Use and addiction. COVID-19\u00a0and increased alcohol consumption: NANOS poll summary report. https:\/\/www.ccsa.ca\/covid-19-and-increased-alcohol-consumption-nanos-poll-summary-report. 2020.[Consult\u00e9 le 24\u00a0juin 2022]."},{"key":"10.1016\/j.therap.2022.06.003_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.therap.2020.06.006","article-title":"Addictovigilance contribution during COVID-19\u00a0epidemic and lockdown in France","volume":"75","author":"Lapeyre-Mestre","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.06.003_bib0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.therap.2019.09.005","article-title":"Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health","volume":"74","author":"Micallef","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.06.003_bib0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1590\/1516-4446-2020-0008","article-title":"Pandemic fear\u201d and COVID-19: mental health burden and strategies","volume":"42","author":"Ornell","year":"2020","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.therap.2022.06.003_bib0080","doi-asserted-by":"crossref","first-page":"e13052","DOI":"10.1111\/jsr.13052","article-title":"Dealing with sleep problems during home confinement due to the COVID-19\u00a0outbreak: Practical recommendations from a task force of the European CBT-I Academy","volume":"29","author":"Altena","year":"2020","journal-title":"J Sleep Res"},{"key":"10.1016\/j.therap.2022.06.003_bib0085","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2215-0366(20)30077-8","article-title":"Online mental health services in China during the COVID-19\u00a0outbreak","volume":"7","author":"Liu","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.therap.2022.06.003_bib0090","unstructured":"Le r\u00e9seau fran\u00e7ais d\u2019addictovigilance. Suivi national d\u2019addictovigilance de la m\u00e9thadone. Rapport d\u2019expertise. Novembre 2019. https:\/\/ansm.sante.fr\/uploads\/2020\/10\/13\/20201013-rapport-methadone-ceip-novembre-2019.pdf. [Consult\u00e9 le 24\u00a0juin 2022 (68\u00a0pp.)]."},{"key":"10.1016\/j.therap.2022.06.003_bib0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PEC.0000000000001970","article-title":"Acute cannabis toxicity","volume":"35","author":"Wong","year":"2019","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.therap.2022.06.003_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7202\/1058609ar","article-title":"D\u00e9finir les troubles li\u00e9s aux substances psychoactives \u00e0 partir de donn\u00e9es administratives","volume":"43","author":"Hu\u1ef3nh","year":"2018","journal-title":"Sant\u00e9 mentale au Qu\u00e9bec"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:22Z","timestamp":1758567382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595722001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0040595722001081"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.06.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalisations apr\u00e8s consommation de substances psychoactives pendant la pand\u00e9mie de COVID-19","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}